In contrast, models of chronic neuroinflammation—such as transgenic AD mice exhibiting sustained microglial activation and amyloid-β accumulation—demonstrate significantly reduced SERT activity in both cortical and hippocampal regions. This evidence concerns the gene SLC6A4 and Alzheimer disease.